Highlights
- Sales over the Year and quarter: The company’s sales declined by -5.42 % over the year, decrease in net sales/revenue by -1.99 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -94.21 %, Marginal increase in other income during this quarter, up by 155.24%.
- Profit over the Year and quarter: Challenges in sustaining profitability for Neuland Laboratories Limited.. Profit dropped by -20.09 % Year to Year, Neuland Laboratories Limited.’s profitability dropped by -16.99 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -20.09 % Year to Year. EPS decreased by -16.99 % in previous quarter. Analysis needed for shareholder value.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 407.073 Cr | Rs. 392.828 Cr | Rs. 385.01 Cr | -1.99 % | -5.42 % |
Expenses | Rs. 287.21 Cr | Rs. 271.56 Cr | Rs. 278.09 Cr | + 2.4 % | -3.18 % |
Operating Profit | Rs. 119.86 Cr | Rs. 121.27 Cr | Rs. 106.92 Cr | -11.83 % | -10.8 % |
OPM % | 29.44 % | 30.87 % | 27.77 % | -3.1 % | -1.67 % |
Other Income | Rs. 92.6 Cr | Rs. 2.1 Cr | Rs. 5.36 Cr | + 155.24 % | -94.21 % |
Interest | Rs. 4.29 Cr | Rs. 3.74 Cr | Rs. 3.61 Cr | -3.48 % | -15.85 % |
Depreciation | Rs. 13.47 Cr | Rs. 15.14 Cr | Rs. 16.46 Cr | + 8.72 % | + 22.2 % |
Profit before tax | Rs. 194.7 Cr | Rs. 104.49 Cr | Rs. 92.21 Cr | -11.75 % | -52.64 % |
Tax % | 23.26 % | 22.1 % | 26.72 % | + 4.62 % | + 3.46 % |
Net Profit | Rs. 84.54 Cr | Rs. 81.39 Cr | Rs. 67.56 Cr | -16.99 % | -20.09 % |
EPS in Rs | Rs. 65.9 | Rs. 63.44 | Rs. 52.66 | -16.99 % | -20.09 % |
Today, we’re looking at Neuland Laboratories Limited.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -5.42 %. However, it did see a marginal slip of -1.99 % from the previous quarter. Expenses ticked up slightly by 2.4 % quarter-on-quarter, aligning with the annual decline of -3.18 %. Operating profit, while down -10.8 % compared to last year, faced a quarter-on-quarter dip of -11.83 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -1.67 %, but a shrinkage of -3.1 % sequentially. Other income rose by 155.24 % compared to the last quarter, despite an annual decline of -94.21 %. Interest expenses dropped significantly by -3.48 % from the previous quarter, yet the year-over-year decrease remains at a moderate -15.85 %. Depreciation costs climbed by 8.72 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 22.2 %. Profit before tax declined annually by -52.64 % but saw a reduction from the preceding quarter by -11.75 %.
Tax expenses as a percentage of profits increased slightly by 3.46 % compared to last year, with a more notable quarter-on-quarter increase of 4.62 %. Net profit fell by -20.09 % year-on-year but witnessed a -16.99 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -20.09 % but a quarterly fall of -16.99 %. In summary, Neuland Laboratories Limited.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 407.073 Cr | Rs. 392.828 Cr | Rs. 385.01 Cr | -1.99 % | -5.42 % |
Expenses | Rs. 287.21 Cr | Rs. 271.56 Cr | Rs. 278.09 Cr | + 2.4 % | -3.18 % |
Operating Profit | Rs. 119.86 Cr | Rs. 121.27 Cr | Rs. 106.92 Cr | -11.83 % | -10.8 % |
Net Profit | Rs. 84.54 Cr | Rs. 81.39 Cr | Rs. 67.56 Cr | -16.99 % | -20.09 % |
EPS in Rs | Rs. 65.9 | Rs. 63.44 | Rs. 52.66 | -16.99 % | -20.09 % |
In reviewing Neuland Laboratories Limited.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -5.42 % year-on-year, although there was a slight dip of -1.99 % from the previous quarter. Expenses decreased by -3.18 % compared to the previous year, with a 2.4 % increase quarter-on-quarter. Operating Profit dropped by -10.8 % annually, and saw a -11.83 % decrease from the last quarter.
Net Profit showed yearly decrease of -20.09 %, and experienced a -16.99 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -20.09 % annually, however dipped by -16.99 % compared to the last quarter. In essence, while Neuland Laboratories Limited. faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.